Strata Skin Sciences, Inc.
SSKN
$1.43
-$0.05-3.06%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 30.98M | 32.85M | 33.62M | 33.56M | 32.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 30.98M | 32.85M | 33.62M | 33.56M | 32.68M |
| Cost of Revenue | 13.09M | 13.85M | 13.95M | 14.46M | 14.53M |
| Gross Profit | 17.89M | 19.00M | 19.67M | 19.10M | 18.14M |
| SG&A Expenses | 23.80M | 24.58M | 23.40M | 23.56M | 23.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.44M | 39.06M | 38.09M | 38.91M | 38.81M |
| Operating Income | -6.46M | -6.21M | -4.47M | -5.35M | -6.14M |
| Income Before Tax | -11.21M | -11.66M | -9.27M | -10.21M | -9.43M |
| Income Tax Expenses | -170.00K | -170.00K | -170.00K | -170.00K | -92.00K |
| Earnings from Continuing Operations | -11.04 | -11.49 | -9.10 | -10.04 | -9.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.04M | -11.49M | -9.10M | -10.04M | -9.34M |
| EBIT | -6.46M | -6.21M | -4.47M | -5.35M | -6.14M |
| EBITDA | -1.93M | -1.30M | 467.00K | -378.00K | -1.12M |
| EPS Basic | -2.62 | -2.77 | -2.20 | -2.58 | -2.59 |
| Normalized Basic EPS | -1.18 | -1.18 | -0.98 | -1.21 | -1.38 |
| EPS Diluted | -2.62 | -2.77 | -2.20 | -2.58 | -2.59 |
| Normalized Diluted EPS | -1.18 | -1.18 | -0.98 | -1.21 | -1.38 |
| Average Basic Shares Outstanding | 17.00M | 16.56M | 15.89M | 15.22M | 14.55M |
| Average Diluted Shares Outstanding | 17.00M | 16.56M | 15.89M | 15.22M | 14.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |